New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide

Daily 20-μg and once-weekly 56.5-μg teriparatide (parathyroid hormone 1–34) treatment regimens increase bone mineral density (BMD) and prevent fractures, but changes in bone turnover markers differ between the two regimens. The aim of the present study was to explain changes in bone turnover markers...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone Res
Hlavní autoři: Tanaka, Sakae, Adachi, Taiji, Kuroda, Tatsuhiko, Nakamura, Toshitaka, Shiraki, Masataka, Sugimoto, Toshitsugu, Takeuchi, Yasuhiro, Saito, Mitsuru, Bilezikian, John P
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4472137/
https://ncbi.nlm.nih.gov/pubmed/26273530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/boneres.2014.43
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky